MEIP logo

MEI Pharma (MEIP)

Profile

Full Name

MEI Pharma, Inc.

Ticker Symbol

MEIP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 18, 2003

Indexes

Not included

Website

http://meipharma.com

Employees

28

Key Details

Price

$1.87(-0.53%)

Market cap

Last Dividend

$1.75

TTM Dividend yield

-

Annual revenue

$65.30M(+33.76% YoY)

Annual EPS

$2.67(+155.86% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.87
MEIP price is $1.87

30-Day Relative Volume

0.46
MEIP 30-day relative volume is 0.46

Price Performance

Price Most recent change

-0.53%
MEIP price was down -0.53% on Apr 11, 2025

Price YTD change

-23.98%
MEIP price is down -23.98% since January 1st

Price 1-year change

-48.48%
MEIP price is down -48.48% year-on-year

Price 3-year change

-82.36%
MEIP price is down -82.36% over the past 3 years

Price Range

Price All-time high

$15720.00
MEIP price is currently -99.99% below its historical high of $15720.00

Price 3-year low

$1.73
MEIP price is currently +8.09% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$12.46M
MEIP market capitalization is $12.46 million

Market cap 3-year change

-82.34%
MEIP market capitalization is down -82.34% over the past 3 years

Market cap All-time high

$726.36M
MEIP market capitalization is currently -98.28% below its historical high of $726.36 million

Market cap sector rank

23.01%
MEIP market capitalization is higher than 23.01% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
MEIP {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+0.08%
MEIP shares outstanding is up +0.08% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.43
MEIP beta is 0.43

200-day SMA

$2.80
MEIP price is currently -33.24% below its 200-day simple moving average

50-day SMA

$2.43
MEIP price is currently -22.91% below its 50-day simple moving average

RSI

19.90
MEIP 14-day relative strength index is 19.90

Volume

0.46
MEIP 30-day relative volume is 0.46

ATR

$0.12
MEIP average true range is $0.12

10-day Historical Volatility

43.27%
MEIP 10-day historical volatility is 43.27%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.75
MEIP last dividend was $1.75 per share, with an ex-dividend date of November 16, 2023

Next Dividend

-
MEIP next dividend has not yet been announced

Dividend per share

Dividend per share

$1.75
MEIP annual dividend per share is $1.75

Dividend per share Sector Rank

65.12%
MEIP annual dividend per share is higher than 65.12% of companies in Healthcare sector

Dividend per share 1-Year Change

-
MEIP annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
MEIP annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

93.58%
MEIP annual dividend yield is 93.58%

Dividend yield Sector Rank

97.65%
MEIP annual dividend yield is higher than 97.65% of companies in Healthcare sector

Other

Payout ratio

65.59%
MEIP annual payout ratio is 65.59%

Dividends paid

$11.66M
MEIP annual dividends paid is $11.66 million

Free cash flow

-$50.48M
MEIP annual free cash flow is -$50.48 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$65.30M
MEIP annual revenue is $65.30 million

Revenue Analysts estimate

-
MEIP annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

+33.76%
MEIP annual revenue is up +33.76% year-on-year

Revenue Sector rank

51.06%
MEIP annual revenue is higher than 51.06% of companies in Healthcare sector

EPS

EPS

$2.67
MEIP annual earnings per share is $2.67

EPS Analysts estimate

-$4.62
MEIP annual earnings per share is currently -157.79% lower than the consensus analysts' forecast

EPS 1-year change

+155.86%
MEIP annual earnings per share is up +155.86% year-on-year

EPS Sector rank

93.31%
MEIP annual earnings per share is higher than 93.31% of companies in Healthcare sector

Profit

Gross profit

-
MEIP annual gross profit value is unknown

Gross margin

-
MEIP annual gross profit margin value is unknown

Operating profit

$25.44M
MEIP annual operating income is $25.44 million

Operating margin

38.96%
MEIP annual operating profit margin is 38.96%

Net income

$17.78M
MEIP annual net profit is $17.78 million

Net margin

27.23%
MEIP annual net profit margin is 27.23%

Expenses

Total expenses

$39.86M
MEIP annual total expenses is $39.86 million

Operating expenses

$39.86M
MEIP annual total operating expenses is $39.86 million

Cost of goods sold

-
MEIP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$23.30M
MEIP annual SGA is $23.30 million

Depreciation and amortization

$383.00K
MEIP annual depreciation & amortization is $383.00 thousand

Interest expense

-
MEIP annual interest expense value is unknown

Income tax

-
MEIP annual income tax value is unknown

EBIT & EBITDA

EBIT

$25.44M
MEIP annual earnings before interest & taxes is $25.44 million

EBITDA

$25.82M
MEIP annual EBITDA is $25.82 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$41.38M
MEIP annual total assets is $41.38 million

Non current assets

$606.00K
MEIP annual long term assets is $606.00 thousand

Current assets

$40.77M
MEIP annual total current assets is $40.77 million

Cash and cash equivalents

$3.71M
MEIP annual cash & cash equivalents is $3.71 million

Accounts receivable

-
MEIP annual accounts receivable value is unknown

Inventory

-
MEIP annual inventory value is unknown

Liabilities

Total liabilities

$8.36M
MEIP annual total liabilities is $8.36 million

Long term liabilities

$0.00
MEIP annual total long term liabilities is $0.00

Current liabilities

$8.36M
MEIP annual total current liabilities is $8.36 million

Accounts payable

$3.17M
MEIP annual accounts payable is $3.17 million

Debt

Total debt

$0.00
MEIP annual total debt is $0.00

Total debt 1-year change

-100%
MEIP annual total debt is down -100% year-on-year

Long term debt

$0.00
MEIP annual long term debt is $0.00

Short term debt

$0.00
MEIP annual short term debt is $0.00

Equity & Capital

Shareholders equity

$33.02M
MEIP annual stockholders equity is $33.02 million

Book value

$33.02M
MEIP annual book value is $33.02 million

Retained earnings

-$388.22M
MEIP annual retained earnings is -$388.22 million

Working capital

$32.41M
MEIP annual working capital is $32.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$50.47M
MEIP annual cash flow from operations is -$50.47 million

Cash from operations 1-year change

+3.83%
MEIP annual cash flow from operations is up +3.83% year-on-year

Cash from investing

$49.14M
MEIP annual cash flow from investing activities is $49.14 million

Cash from investing 1-year change

-8.47%
MEIP annual cash flow from investing activities is down -8.47% year-on-year

Cash from financing

-$11.87M
MEIP annual cash flow from financing activities is -$11.87 million

Cash from financing 1-year change

-29570%
MEIP annual cash flow from financing activities is down -29570% year-on-year

CAPEX

CAPEX

$7000.00
MEIP annual capital expenditures is $7000.00

CAPEX 1-year change

-80%
MEIP annual capital expenditures is down -80% year-on-year

Free Cash Flow

Free cash flow

-$50.48M
MEIP annual free cash flow is -$50.48 million

Free cash flow 1-year change

+3.88%
MEIP annual free cash flow is up +3.88% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MEIP annual gross profit margin value is unknown

Operating margin

38.96%
MEIP annual operating profit margin is 38.96%

Net margin

27.23%
MEIP annual net profit margin is 27.23%

ROA & ROE

ROA

21.92%
MEIP annual return on assets is 21.92%

ROE

61.68%
MEIP annual return on equity is 61.68%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MEIP price to earnings ratio value is unknown

PE ratio Sector rank

-
MEIP price to earnings ratio is unknown

PB Ratio

PB ratio

0.56
MEIP price to book ratio is 0.56

PB ratio Sector rank

31.91%
MEIP price to book ratio is higher than 31.91% of companies in Healthcare sector

PS Ratio

PS ratio

-
MEIP price to sales ratio value is unknown

PS ratio Sector rank

-
MEIP price to sales ratio is unknown

Enterprise value

Enterprise value

-$11.28M
MEIP enterprise value is -$11.28 million

Enterprise value Sector rank

4.62%
MEIP enterprise value is higher than 4.62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.39
MEIP EV/EBITDA is 0.39

EV/EBITDA Sector rank

71.09%
MEIP EV/EBITDA is higher than 71.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.88
MEIP annual current ratio is 4.88

Quick ratio

-
MEIP annual quick ratio value is unknown

Leverage

Debt to equity

0.00
MEIP annual debt to equity ratio is 0.00

Interest coverage ratio

-
MEIP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MEIP piotroski f-score value is unknown

Altman Z-Score

-7.69
MEIP altman z-score is -7.69

Analyst ratings

Recent major analysts updates

Jul 23, 24 Laidlaw & Co.
Hold
Apr 12, 24 Stifel
Hold
Feb 14, 24 Stifel
Hold
Sep 27, 23 Stifel
Hold
May 23, 23 Brookline Capital
Buy
May 12, 23 Stifel
Hold
Feb 13, 23 HC Wainwright & Co.
Buy
Feb 8, 23 Jefferies
Underperform
Dec 6, 22 Truist Securities
Hold
Dec 6, 22 BTIG
Neutral

Institutional Ownership

Similar stocks

ALLR logo
Allarity Therapeutics (ALLR)
IMNN logo
Imunon (IMNN)
BOLT logo
Bolt Biotherapeutics (BOLT)
BRTX logo
BioRestorative Therapies (BRTX)
MetaVia (MTVA)
INAB logo
IN8bio (INAB)
ONMD logo
OneMedNet (ONMD)
CRIS logo
Curis (CRIS)
PSTV logo
Plus Therapeutics (PSTV)
  • What is the ticker symbol for MEI Pharma?
  • Does MEI Pharma pay dividends?
  • What sector is MEI Pharma in?
  • What industry is MEI Pharma in?
  • What country is MEI Pharma based in?
  • When did MEI Pharma go public?
  • Is MEI Pharma in the S&P 500?
  • Is MEI Pharma in the NASDAQ 100?
  • Is MEI Pharma in the Dow Jones?
  • When was MEI Pharma's last earnings report?
  • When does MEI Pharma report earnings?
  • Should I buy MEI Pharma stock now?

What is the ticker symbol for MEI Pharma?

The ticker symbol for MEI Pharma is NASDAQ:MEIP

Does MEI Pharma pay dividends?

No, MEI Pharma does not pay dividends

What sector is MEI Pharma in?

MEI Pharma is in the Healthcare sector

What industry is MEI Pharma in?

MEI Pharma is in the Biotechnology industry

What country is MEI Pharma based in?

MEI Pharma is headquartered in United States

When did MEI Pharma go public?

MEI Pharma's initial public offering (IPO) was on December 18, 2003

Is MEI Pharma in the S&P 500?

No, MEI Pharma is not included in the S&P 500 index

Is MEI Pharma in the NASDAQ 100?

No, MEI Pharma is not included in the NASDAQ 100 index

Is MEI Pharma in the Dow Jones?

No, MEI Pharma is not included in the Dow Jones index

When was MEI Pharma's last earnings report?

MEI Pharma's most recent earnings report was on Feb 12, 2025

When does MEI Pharma report earnings?

The next expected earnings date for MEI Pharma is May 9, 2025

Should I buy MEI Pharma stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page